KR20080092384A - 사멸 또는 비감염성 박테리아 제제를 사용한염증성장증후군의 조절 - Google Patents

사멸 또는 비감염성 박테리아 제제를 사용한염증성장증후군의 조절 Download PDF

Info

Publication number
KR20080092384A
KR20080092384A KR1020087017840A KR20087017840A KR20080092384A KR 20080092384 A KR20080092384 A KR 20080092384A KR 1020087017840 A KR1020087017840 A KR 1020087017840A KR 20087017840 A KR20087017840 A KR 20087017840A KR 20080092384 A KR20080092384 A KR 20080092384A
Authority
KR
South Korea
Prior art keywords
gram
positive
mice
disease
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020087017840A
Other languages
English (en)
Korean (ko)
Inventor
질르 마르샬
미슈린느 라그랑드리
모하매드 아볼하싸니
에르베 베르꼬비에
Original Assignee
앵스띠뛰 파스퇴르
이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 앵스띠뛰 파스퇴르, 이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 filed Critical 앵스띠뛰 파스퇴르
Publication of KR20080092384A publication Critical patent/KR20080092384A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/32—Mycobacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020087017840A 2005-12-21 2006-12-21 사멸 또는 비감염성 박테리아 제제를 사용한염증성장증후군의 조절 Withdrawn KR20080092384A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2,531,261 2005-12-21
CA002531261A CA2531261A1 (en) 2005-12-21 2005-12-21 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria

Publications (1)

Publication Number Publication Date
KR20080092384A true KR20080092384A (ko) 2008-10-15

Family

ID=38175409

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087017840A Withdrawn KR20080092384A (ko) 2005-12-21 2006-12-21 사멸 또는 비감염성 박테리아 제제를 사용한염증성장증후군의 조절

Country Status (10)

Country Link
US (1) US20090280146A1 (https=)
EP (1) EP1971352A2 (https=)
JP (1) JP2009520810A (https=)
KR (1) KR20080092384A (https=)
CN (1) CN101384270A (https=)
AU (1) AU2006327761A1 (https=)
CA (2) CA2531261A1 (https=)
IL (1) IL192048A0 (https=)
MX (1) MX2008008157A (https=)
WO (1) WO2007072230A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2087898A1 (en) * 2008-02-06 2009-08-12 Institut Pasteur A preparation of mycobacterium bovis BCG killed by extended freeze drying (EFD) for treating rheumatoid arthritis
CA2629057A1 (en) * 2008-04-14 2009-10-14 Institut Pasteur Control of diseases associated with decrease of t-regulatory cells with a preparation of extended freeze-dried killed bacteria
EP2292260A1 (en) 2009-08-13 2011-03-09 Institut Pasteur Use of mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis
NZ702796A (en) * 2010-07-26 2017-03-31 Qu Biologics Inc Immunogenic anti-inflammatory compositions
WO2013004069A1 (zh) * 2011-07-05 2013-01-10 苏州科景生物医药科技有限公司 沙门氏菌鞭毛蛋白衍生物在制备防治炎症性肠病药物中的应用
US9886742B2 (en) 2016-03-17 2018-02-06 Google Llc Electro-optic beam steering for super-resolution/lightfield imagery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR012304A1 (es) * 1997-04-01 2000-10-18 Borody Thomas J Composiciones y metodos para el tratamiento de enfermedades intestinales inflamatorias y el uso de dicha composicion para preparar medicamentos paradichos tratamientos.
WO1998047520A1 (en) * 1997-04-24 1998-10-29 Lovelace Respiratory Research Institute Prevention and treatment of allergic disease by targeted development of protective t-helper lymphocyte immunity
AUPQ776100A0 (en) * 2000-05-26 2000-06-15 Australian National University, The Synthetic molecules and uses therefor
GB0106987D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeuitic agent
EP2316466B1 (en) * 2001-12-11 2013-08-21 Institut Pasteur Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
JP2005531289A (ja) * 2002-02-15 2005-10-20 アゲルプ ファーマ ゲーエムベーハー Ｓ．ａｕｒｅｕｓエンテロトキシンＢ由来の免疫調節ペプチド

Also Published As

Publication number Publication date
CN101384270A (zh) 2009-03-11
IL192048A0 (en) 2009-02-11
WO2007072230A3 (en) 2007-11-22
AU2006327761A1 (en) 2007-06-28
CA2632839A1 (en) 2007-06-28
WO2007072230A2 (en) 2007-06-28
EP1971352A2 (en) 2008-09-24
MX2008008157A (es) 2008-09-24
JP2009520810A (ja) 2009-05-28
CA2531261A1 (en) 2007-06-21
US20090280146A1 (en) 2009-11-12

Similar Documents

Publication Publication Date Title
JP5417354B2 (ja) 免疫調節不全を含む疾患の治療のためのグラム陽性細菌調製物
US8512694B2 (en) Method of producing rough strains of bacteria and uses thereof
CN101138573A (zh) 酪酸梭菌、凝结芽孢杆菌制备治疗炎症性肠病药物中的应用
KR20080092384A (ko) 사멸 또는 비감염성 박테리아 제제를 사용한염증성장증후군의 조절
FI120136B (fi) Mycobacterium vaccae immuunijärjestelmän Th2-aktiivisuuden hillitsemiseksi
US6723327B1 (en) Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
US20180333439A1 (en) Attenuated or inactivated pathogenic escherichia coli for treating urogenital cancer
CA2571886A1 (en) Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
US20040247622A1 (en) Methods and compounds for the treatment of immunologically-mediated diseases using Mycobacterium vaccae
van der Meijden Non specific immunotherapy with BCG-RIVM in superficial bladder cancer: histological, immunological and therapeutic aspects
Schreinemachers et al. Intravesical and Intradermal Bacillus Calmette-Guérin Application
HK1067073B (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000